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ABSTRACT: Gold-silver core-shell nanoparticles stabilized with a 
common sweetener, aspartame (AuNP@Ag@Asm) combine the 
antimicrobial properties of silver with photoinduced plasmon-
mediated photothermal effects of gold. The particles were tested with 
several bacterial strains, while biocompatibility was verified with hu-5 
man dermal fibroblasts. 
When a metal nanoparticle interacts with light of a wavelength longer 
than the dimensions of the particle itself, Surface Plasmon Resonance 
(SPR) phenomenon can lead to characteristic light absorption due to 
the coherent oscillation of the surface electrons induced by the light.1 10 
Particularly interesting are the cases of gold, silver and copper, where 
the SPR absorptions occur in the visible range. Variation on the region 
of absorption can be achieved by changing the size, shape or composi-
tion of the particles.2 This effect has been investigated and used for 
several applications, which range from catalysis3 to biochemistry.4,5 15 
Three known properties of noble metal nanoparticles stimulated the 
research reported here: (a) Upon light absorption gold nanoparticles 
(AuNP) can deliver energy with pinpoint precision,6 high efficiency 
and in subpicosecond time scales. This property has been proposed as 
a powerful tool for photodynamic therapy (PDT), a light-mediated 20 
form of clinical treatment;4,7 (b) Silver nanoparticles (AgNP) have 
excellent antimicrobial properties that exceed those of silver ions 
themselves, and it has been proposed that the AgNP themselves are 
strongly anti-infective, beyond any effect due to Ag+ leaching8,9 and (c) 
peptides, such as LL37 can stabilize metal nanoparticles, such as AgNP, 25 
while they retain their antiinfective properties and showing excellent 
biocompatibility.10 Based on this observation, we present here the 
remarkable behavior of core-shell gold-silver nanostructures stabilized 
with aspartame (Asm), a common artificial sweetener. (Figure 1). 
 30 
Figure 1: Aspartame molecular structure. 
The material presented in this contribution consists of a gold core, 
encapsulated in a silver shell11,12 and stabilized with a dipeptide, specifi-
cally aspartame.  The gold core has been chosen for the purpose of 
efficient heat delivery through established plasmonic mechanisms.13 35 
The silver shell retains the antibacterial properties that have been 
characterized for AgNP. The surface protection with aspartame leads 
to excellent aqueous stabilization with long shelf life. Further, aspar-
tame is non-toxic,14 remarkably inexpensive and easy to replace if other 
molecules with specific biological targets are desirable for surface 40 
coating. Moreover, in addition to the synthesis and characterization of 
aspartame stabilized Au/Ag nanostructures (AuNP@Ag@Asm), 
representative in vitro experiments were carried out as a first indication 
of their antibacterial properties. Indeed, the effect of light activation 
and their biocompatibility were tested with primary human dermal 45 
fibroblasts (ATCC). 
AuNP seeds (~12 nm) were used for seed-mediated growth of core-
shell nanoparticles.15 The synthesis of AuNP seeds was done via an 
established procedure.11 Briefly, an aqueous solution of 0.33 mM 
HAuCl4 and 1 mM I-2959 (1:3 stoichiometric ratio) was irradiated 50 
with UVA light, using a Luzchem LZC-4 photoirradiator, for 15 
minutes. After irradiation, the solution was left in the dark for at least 
24 hours before surface functionalization with silver. A seed-mediated 
growth procedure was employed for the formation of Au/Ag core-shell 
nanoparticles according to a reported procedure,11 but replacing the 55 
citrate stabilizer with two biocompatible stabilizing agents, aspartame, 
as indicated above, and LL37. We emphasize here the results with 
aspartame. The concentration of AgNO3 was chosen to have nanopar-
ticles in which the core represents the same metal loading with respect 
to the shell (Au/Ag = 50/50). Briefly, an aqueous solution of 110 μM 60 
AgNO3, 4 μM of aspartame and 110 μM I-2959 was purged under N2 
for 45 minutes. After purging, 1 mL of AuNP seeds was added to the 
cuvette and irradiated for 15 minutes with UVA light. Absorbance 
spectra were taken before and after irradiation, as reported below. 
 65 
O
OCH3N
H
O
NH2
O
OH
OHO
OH
O
I-2959
OH
hν
OHO
O
Benzoyl radical oxidation
air
OHO
O
OH
HEBA
ketyl
radical
OHO
O
OH +   Mn+ O +   M(n-1)+   +  H+
Page 2 of 6
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 Scheme 1. I-2959 photolysis and metal ion reduction that subsequent-
ly leads to metal nanoparticle formation.  
Formation of AuNP@Ag@Asm led to the spectral changes of Figure 2. 
Note that after irradiation with AgNO3 the band corresponding to the 
Au plasmon absorption is shifted to the blue, while a new band, corre-70 
sponding to the Ag plasmon absorption and centered at 405 nm ap-
pears. The intensity of the two absorptions is consistent with the pres-
ence of comparable amounts of Au and Ag. Moreover, after the initial 
stabilization of the particles formed, the UV spectra did not change 
with time, showing a very high stability. The analysis of the UV-Vis 75 
spectra furnished a clear indication that core-shell structures are 
formed as opposed to separate nanoparticles or alloys. Indeed, in those 
cases we would have had no shift of the plasmon maximum (single 
particles) or a single band between the two metal plasmon absorptions 
(alloy).16 80 
 
Figure 2: Absorption spectra for core-shell nanoparticles stabilized 
with aspartame (AuNP@Ag@Asm), recorded before irradiation (red 
trace), right after irradiation in the presence of AgNO3 (black trace) 
and at different times after the irradiation was completed (blue to 85 
orange traces). The maxima of the two bands obtained after irradiation 
are centered at 405 and 510 nm.  
In order to establish the structure and size of AuNP@Ag@Asm parti-
cles, TEM images were taken and analyzed for different samples. The 
images obtained reveal clearly that AuNP@Ag@Asm are spherical with 90 
an average diameter of 16.6 ± 4.7 nm (n = 497). The particles present a 
darker central region, attributed to the gold core, as well a lighter sec-
tion around it, representing the silver shell, see Figure 3. 
 
Figure 3: Transmission electron microscope image for 95 
AuNP@Ag@Asm. The scale bar of the image represents 20 nm. Core-
shell nature of the nanoparticles can be easily visualized. The inset 
represents a histogram of the size distribution of the nanoparticles, 
which yields a mean diameter of ~17 nm (n = 497). 
EDS analysis was performed for AuNP@Ag@Asm and the relative 100 
average percent (%) composition revealed 45.8 ± 1.6 % silver and 54.2 
±1.7 % gold, similar to the anticipated composition based on the 
amount of HAuCl4 (110 μM) and silver nitrate (110 μM) respectively. 
The EDS spectra, reported in the SI, confirmed the metal composition 
of the core-shell particles formed. The presence of traces of carbon and 105 
chlorine ions was also detected and it was attributed to residues of the 
by-product 4-hydroxyethoxybenzoic acid (HEBA) and the starting 
material HAuCl4, respectively. The presence of HEBA in these materi-
als is well established.11,17 
In addition, the antimicrobial properties of the particles synthesized 110 
were tested, by performing Minimal Inhibitory Concentration (MIC) 
experiments via a microdilution assay. Information regarding the setup 
used is reported in the SI. Briefly, two identical 96-well plates were 
prepared using particles concentrations in the range of 0-25 µM. The 
choice of the concentrations was based on the hypothesis that 115 
AuNP@Ag@Asm would have somewhat similar MIC values as other 
silver-containing particles.10 Three different bacteria strains, Staphylo-
coccus aureus ATTC 25923, Staphylococcus epidermidis SE19 and Esche-
richia coli CF073, were analyzed. Parallel experiments of identical 
plates in the dark or under 530 nm LED irradiation were held for 18 120 
hours at 37°C and the resulting OD of the bacterial suspensions was 
measured.  
The results obtained for each strains analyzed are reported in Figure 4. 
 
Figure 4: Concentration dependent graphs depicting microbial inhibi-125 
tion action by AuNP@Ag@Asm via measurement of the optical densi-
ty for E. coli (A), S. aureus (B) and S. epidermidis (C). The legend 
denotes experiments as either irradiated (LIGHT) or non-irradiated 
(DARK). Optical density measurements were taken at 620 nm. Panel 
D shows the experimental set up, with the well plate under intense 130 
LED illumination. 
In the presence of AuNP@Ag@Asm the MIC value is lower for irradi-
ated experiments than non-irradiated experiments. Therefore, the 
amount of AuNP@Ag@Asm needed to inhibit bacterial growth is 
lower under light exposure. This effect can either be due to the irradia-135 
tion itself, or to the heat emitted by the AuNP@Ag@Asm from plas-
mon excitation at 530 nm. In order to verify that it is in fact the photo-
thermal properties of the gold core causing microbial inhibition, con-
trol experiments were performed. In each experiment, the measure-
ment of the OD in the absence of nanoparticles was taken, and signifi-140 
cant bacterial density was visualized in both irradiated and non-
irradiated conditions. Therefore, the lower MIC value for irradiated 
experiments should be attributed to the synergistic effect of the photo-
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 thermal properties of gold and the antimicrobial action of the silver 
shell and not to the direct cell irradiation effect.  Note that 530 nm 145 
irradiation of AgNP (no gold) does not enhance their antibacterial 
properties (see S9 in Supporting Information). 
A summary of the results obtained is presented in Table 1 for further 
comparison. It was reported that AuNP by themselves need a higher 
concentration to completely inhibit microbial growth.18 In order to 150 
decrease the MIC of gold nanoparticles, a shell of a material with well 
known antibacterial properties was added. This strategy will allow for 
synergistic inhibitory properties. 
 
Table 1: Cumulative minimal inhibitory concentration results (µM) 155 
from the analysis of MIC data.a 
 AuNPb AuNP@Ag@LL37 
AuNP@Ag@As
m 
Bacterial 
strains L D L D L D 
S. aureus >25 >25 6.25 25 6.25 12.5 
S.epiderm
idis >25 >25 3.13 12.5 3.13 12.5 
E.coli >25 >25 6.25 25 3.13 ≥25 
a Labels D and L stand for dark and light, respectively. 
b Values as high as 2 mM have been reported under similar 
conditions.18 
 160 
Although experiments above attest the microbial inhibition via 
AuNP@Ag@Asm, a kinetic study of antibacterial activity was also 
performed for the three strains during a period of 18 hours at MIC 
concentrations. Bactericidal activity denotes 99.9% killing of inoculum 
with a particular antimicrobial agent. Time kill curves were constructed 165 
by plating bacterial cultures containing the antimicrobial agent at 
specific time intervals (0-18 hours). Four different conditions were 
considered employing: (1) AuNP@Ag@Asm at MIC concentration 
under 530 nm irradiation; (2) AuNP@Ag@Asm at MIC concentration 
in the dark; (3) no AuNP@Ag@Asm and 530 nm irradiation; (4) no 170 
AuNP@Ag@Asm in the dark. 
Irradiated and non-irradiated experiments were conducted in order to 
measure bactericidal capabilities for AuNP@Ag@Asm and the photo-
thermal activity of gold. The results obtained are shown in Figure 5. 
They reveal that in the dark cell killing is incomplete (even when below 175 
the detection limit), as cells eventually recover.  In contrast, illumina-
tion causes complete cell death, with no hint of recovery. 
As previously mentioned, for each bacteria strain, two control experi-
ments were performed, both in absence of AuNP@Ag@Asm, under 
530 nm irradiation and in the dark. In all cases, there are no significant 180 
differences between the amounts of survivors. In fact, for the last 6-18 
hours both controls of non-irradiated and irradiated experiments, in 
absence of AuNP@Ag@Asm, held constant values of the log of 
CFU/mL (~5). This further corroborates what was seen in the con-
trols for the MIC experiments: when bacterial cultures are irradiated in 185 
the absence of nanoparticles, there is no negative impact on their 
growth or survival. In other words, there is not direct effect of the light 
on the microbial growth.  
 
 190 
Figure 5: Time-kill curves recorded at t= 0, 1, 3, 6, 9 and 18 h, for E. 
coli (A), S. aureus (B) and S. epidermidis (C). The experiments were 
conducted using AuNP@Ag@Asm at MIC concentration, under 530 
nm irradiation (blue traces) and in the dark (black traces). Controls 
experiments in absence of AuNP@Ag@Asm were also performed 195 
under irradiation (green trace) and in the dark (brown traces). 
 
When using AuNP@Ag@Asm, in absence of light a particular trend 
was observed. For E. coli, a decrease of the bacteria growth was record-
ed until t= 6 h, however, at t= 9 h, t= 12 h, and t= 18 h, a dramatic 200 
growth was observed. For S.aureus and S.epidermidis no survival colo-
nies were apparent at t= 6 h, however, a significant amount (difference 
of >3 log10 fold) of bacterial colonies was seen for t= 18 h. Thus, almost 
complete bactericidal activity was seen at t= 6 h for non-irradiated 
experiments but significant amount of colonies were seen at t= 18 h 205 
suggesting loss of bactericidal activity. This may be explained consider-
ing that as much as 0.01% of the inoculum could remain after 6 h and 
grow for the remaining time. The mere presence of AuNP@Ag@Asm 
is not sufficient for a complete kill of the bacteria. In contrast, irradiated 
experiments in presence of AuNP@Ag@Asm (Figure 5, blue bars) 210 
show efficient bactericidal activity. At t= 6 h, no survival colonies were 
counted as well as a difference of 3 log10-fold was recorded. This trend 
was maintained also after t=18 h. Therefore, the antimicrobial contri-
bution of silver is supplemented by irradiation of AuNP@Ag@Asm 
leading to a lasting antimicrobial efficiency. Therefore, it is the combi-215 
nation of the silver antibacterial properties with gold photothermal 
effect that makes AuNP@Ag@Asm a remarkably efficient material. 
Cell viability information was obtained employing a colorimetric assay 
(MTS assay) for aspartame, AuNP@Ag@Asm, AgNP@citrate and 
AuNP (see SI). No significative effect on the proliferation of primary 220 
dermal human skin fibroblasts at different concentration of 
AuNP@Ag@Asm was observed. However, a slightly lower prolifera-
tion of cells treated with AgNP (although within the experimental 
error) was obtained, probably due to the release of Ag1+ ions.19  
Moreover, TEM images (Figure 6) showed a marked difference in the 225 
behavior of S. aureus and E. coli. After 1 hour of incubation, 
AuNP@Ag@Asm are located around the S. aureus membrane, possi-
bly due to an electrostatic interaction with the peptidoglican of this 
Gram positive strain. However, after the same time of interaction, the 
AuNP@Ag@Asm form small aggregates inside the E. coli bacillus, 230 
indicating that possible uptake mechanisms may take place in this case, 
as it does for AgNP.9 However, both strains present symptoms of 
membrane structural damage, which is likely attributed to the antibac-
terial properties of silver. 
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  235 
 
Figure 6: TEM images of Staphylococcus aureus ATTC 25923 (A and 
B) and Escherichia coli CF073 (C and D) show the interaction between 
AuNP@Ag@Asm and the bacterial wall after 1 h of incubation at 37°C. 
 240 
In conclusion, bimetallic core-shell nanoparticles allow for the exploita-
tion of properties characterstic for monometallic (Au and Ag) nano-
particles. Under irradiation, AuNP@Ag@Asm presented effective 
inhibitory microbial properties. Further, irradiating the nanoparticles 
in order to exploit the photothermal properties of gold was shown to 245 
increase inhibitory properties when compared to unirradiated AuNP 
and AgNP. This finding suggests a synergistic effect between the silver 
antimicrobial properties and the photothermal effects due to the gold 
core. The combined effect of silver and gold allowed for complete 
bactericidal activity whereas non-combinatorial (or non-irradiated 250 
experiments) did not. We suggest that thanks to the core-shell nano-
particles’ synergistic properties, the material proposed represents an 
attractive antibacterial agent since the photothermal properties of gold 
can compensate if the silver antimicrobial properties do not suffice for 
complete bactericidal activity. Aspartame stabilization provides good 255 
shelf life for the particles with a material that is non-toxic, inexpensive 
and water soluble. 
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